Kpcb Xv Associates, LLC Atara Biotherapeutics, Inc. Transaction History
Kpcb Xv Associates, LLC
- $35.8 Million
- Q3 2022
A detailed history of Kpcb Xv Associates, LLC transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, Kpcb Xv Associates, LLC holds 1,876,650 shares of ATRA stock, worth $16 Million. This represents 19.79% of its overall portfolio holdings.
Number of Shares
1,876,650
Previous 1,876,650
-0.0%
Holding current value
$16 Million
Previous $14.6 Million
51.47%
% of portfolio
19.79%
Previous 26.96%
Shares
1 transactions
Others Institutions Holding ATRA
# of Institutions
10Shares Held
3.07MCall Options Held
0Put Options Held
0-
Antipodean Advisors LLC New York, NY1MShares$8.51 Million8.12% of portfolio
-
Boxer Capital, LLC San Diego, CA166KShares$1.41 Million0.08% of portfolio
-
Lake Street Advisors Group, LLC11KShares$93,6100.0% of portfolio
-
Ifp Advisors, Inc4.5KShares$38,2950.0% of portfolio
-
American Portfolios Advisors Holbrook, NY4.5KShares$38,2950.0% of portfolio
About Atara Biotherapeutics, Inc.
- Ticker ATRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,362,304
- Market Cap $803M
- Description
- Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...